Creative Planning
ZYNE

Creative Planning’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Creative Planning’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-200
Closed -$1K – 4896
2017
Q1 		$1K Buy
+200
New +$3.97K ﹤0.01% 4529

Creative Planning's ZYNE Position: Q4 2023 in Review

Creative Planning sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 100 shares — an estimated $128 sold.

Creative Planning first reported a position in ZYNE in Q4 2016 and held it in 4 quarters. The position peaked at $15K in Q2 2017. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

  • Creative Planning reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
  • Creative Planning sold 100 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $128.
  • Creative Planning first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2016 and held it in 4 quarters.
  • Creative Planning's Zynerba Pharmaceuticals, Inc position peaked at $15K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Creative Planning's 13F filing for Q4 2023, filed 14 Feb 2024.